Skip to the page

Data / Medical devices / Israel / Medinol Ltd.

Medinol Ltd.: FDA-registered device maker in Jerusalem, Israel, 2 510(k) clearances and 1 PMA approval

Medinol Ltd. is registered with the FDA (registration 3003084171) in Jerusalem, Israel. It lists 2 device types. The FDA files 2 510(k) clearances and 1 PMA approval under its listings, the newest dated January 25, 2018. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3003084171
FEI number
3003182398
Address
8 Hartom Street Beck Tech Bldg. Har Hotzvim B, Jerusalem, Israel, 9777508
Owner or operator
MEDINOL LTD. (9031416)
Roles
Complaint file establishment, Manufacturer
First device listed
January 22, 2017
Registered through
2027
Brand names listed
EluNIR™ Ridaforolimus Eluting Coronary Stent System, Gallant PTCA Dilatation Catheter, NC Gallant PTCA Dilatation Catheter

Devices it lists

DeviceProduct codeClassRoleSource
Catheters, Transluminal Coronary Angioplasty, PercutaneousLOX2Complaint file establishment, Manufactureraccessdata.fda.gov
Coronary Drug-Eluting StentNIQ3Complaint file establishment, Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
January 25, 2018K173581Gallant PTCA Dilatation CatheterLOXSubstantially EquivalentMedinol, Ltd.accessdata.fda.gov
January 19, 2017K162434NC Gallant PTCA CatheterLOXSubstantially EquivalentMedinol, Ltd.accessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
November 28, 2017P170008EluNIR™ Ridaforolimus Eluting Coronary Stent SystemNIQ54August 6, 2026accessdata.fda.gov

Compare with other makers

Updated August 6, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.